Cytek Biosciences, Inc. (CTKB) Misses Q3 EPS by 1c, Beats on Revenue

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $52.3 million versus the consensus estimate of $51.03 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trifecta Gold closes $1.66M private placement for Yukon exploration
• Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight